Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Opioid-Induced Constipation 3Vomiting 1Neoplasms 1Nausea 1Constipation 1

Interventions

alvimopan 6tegaserod 3naloxegol 2Standard of Care 2Naloxone 2polyethylene glycol 3350 1oxycodone-acetaminophen 1oxycodone naloxone combination 1naldemedine 1methylnaltrexone 1ma zi ren wan 1isatuximab 1Videotape Recording 1Tramadol 1Sutures 1Surveys and Questionnaires 1Surgical Instruments 1Sennosides 1Quality of Life 1Proteins 1Phenolphthalein 1Oxycodone 1Orphenadrine 1Octreotide 1Nicotine 1Morphine 1Methadone 1Lidocaine 1Ketorolac Tromethamine 1Ketorolac 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Constipation × naldemedine × Clear all
NCT07038551 2025-07-02

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

International University of Health and Welfare

Phase 4 Recruiting
120 enrolled
Other

Opioid-Induced Constipation, Constipation, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡